Cargando…

High prevalence of a BRCA1 gene founder mutation, 5083del19, in unselected breast–ovarian cancer patients from Southern Italy: genotype–phenotype correlations

Detalles Bibliográficos
Autores principales:	Baudi, F, Lavecchia, AM, Quaresima, B, Faniello, MC, De Paola, L, D'Amico, W, Fabiani, F, Cuda, G, Costanzo, FS, Venuta, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233512/ http://dx.doi.org/10.1186/bcr1091

Ejemplares similares

Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies
por: Bianco, Aida, et al.
Publicado: (2013)

Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications
por: Scumaci, Domenica, et al.
Publicado: (2015)

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
por: Tassone, P, et al.
Publicado: (2003)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
por: Ottini, Laura, et al.
Publicado: (1999)

Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South Italy
por: Gallo, Luigia, et al.
Publicado: (2016)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
por: Li, Jingmei, et al.
Publicado: (2018)

Founder BRCA1 mutations in Nepalese population
por: Mehta, Anurag, et al.
Publicado: (2022)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
por: Koumpis, Chrissovaladis, et al.
Publicado: (2011)

Identification of a founder BRCA2 mutation in Sardinia
por: Pisano, M, et al.
Publicado: (2000)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Proteomics Analysis to Assess the Role of Mitochondria in BRCA1-Mediated Breast Tumorigenesis
por: Concolino, Antonio, et al.
Publicado: (2018)

BRCA1 and BRCA2 mutations in central and southern Italian patients
por: Ottini, Laura, et al.
Publicado: (2000)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
por: Hernández, Julián Esteban Londoño, et al.
Publicado: (2014)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
por: Muhammad, Noor, et al.
Publicado: (2023)

Comparing the Corrosion Resistance of 5083 Al and Al(2)O(3)3D/5083 Al Composite in a Chloride Environment
por: Yu, Liang, et al.
Publicado: (2022)

Evidence of a founder BRCA1 mutation in Scotland
por: Liede, A, et al.
Publicado: (2000)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)

Finished rings in AW5083 for CMS external cylinders
por: Dembiermont
Publicado: (2001)

A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy
por: D’Amico, Adele, et al.
Publicado: (2020)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

A Founder Mutation of the BRCA1-Gene in Western Sweden
por: Einbeigi, Zakaria, et al.
Publicado: (1999)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
por: Liu, Yun, et al.
Publicado: (2021)

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000)

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H, et al.
Publicado: (2017)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

Ring rolling of AW5083 large rings for the external cylinder of CMS
por: S. Sgobba / EST
Publicado: (2001)

Protective Performance of Polyaniline-Sulfosalicylic Acid/Epoxy Coating for 5083 Aluminum
por: Liu, Suyun, et al.
Publicado: (2018)

High-Cycle Fatigue Behaviour of the Aluminium Alloy 5083-H111
por: Nečemer, Branko, et al.
Publicado: (2023)

Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort
por: Schiabor Barrett, Kelly M., et al.
Publicado: (2022)

Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients
por: Zhong, Xiaorong, et al.
Publicado: (2016)

Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation
por: Zolea, Fabiana, et al.
Publicado: (2016)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
por: Solano, Angela R., et al.
Publicado: (2018)

BRCA1 4153delA founder mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_92pp5rf0oes8nou1t5n4069nkq